| Literature DB >> 31546796 |
Xianrong Zhou1, Jin Shang2, Mingyi Qin3, Jianhua Wang4, Bo Jiang5, Hui Yang6, Yan Zhang7.
Abstract
Polymethylene-interrupted polyunsaturated fatty acids (PMI-PUFAs) are emerging functional lipids with proven antioxidant and anti-inflammatory effects. In this study, a typical PMI-PUFA, sciadonic acid (C20:3, 5c 11c 14c), was enriched in the kernel oil of Torreya fargesii (T. fargesii) by fractionation. Fractionated kernel oil of T. fargesii (containing 25% sciadonic acid) showed equal stability and similar radical scavenging ability compared with the non-fractionated oil. In anti-inflammatory tests, fractionated kernel oil was shown to inhibit the activity of phosphodiesterase (PDE-5, efficiency 80% at 133.7 μg/mL) and lipoxygenase-5 (LOX-5, efficiency 65% at 66.7 μg/mL) more effectively than the non-fractionated oil. This shows that increasing the amount of sciadonic acid can enhance the anti-inflammatory effect of the kernel oil. This research also indicates that fractionation is a feasible way to obtain sciadonic acid-rich functional oil with potential pharmacological effects.Entities:
Keywords: Torreya; anti-inflammation; antioxidant effect; kerneloil; sciadonic acid
Mesh:
Substances:
Year: 2019 PMID: 31546796 PMCID: PMC6767029 DOI: 10.3390/molecules24183402
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The typical polymethylene-interrupted polyunsaturated fatty acids (PMI-PUFA) and seed of Torreyafargesii.
Properties and fatty acid (content higher than 1%) composition of different Torreya kernel oils.
| Fractionated | |||
|---|---|---|---|
| Color (Lovibond 1.0 inch) | Y30 + R1 | Y30 + R0.5 | - |
| Viscority 20 °C, mPa.s | 55–90 | 60–90 | - |
| Density, 20 °C, g/cm3 | 0.920–0.930 | 0.910–0.930 | - |
| Acid value (AV), mg KOH/g | 0.35 ± 0.01 a | 0.33 ± 0.01 a | 0.2–3 |
| Peroxide value (PV), meq/g | 0.56 ± 0.05 a | 0.49 ± 0.04 a | 0.1–1 |
| Iodine value (IV), g I2/100g | 145 ± 1.8 a | 161 ± 2.0 b | 130–150 |
| Saponification value, mg KOH/g | 186 ± 2.3 a | 188 ± 2.6 a | 180–200 |
| Unsaponifiable matter, % | 0.82 ± 0.05 a | 0.76 ± 0.05 a | - |
| Wax, % | 2.12 ± 0.25 a | 0.05 ± 0.00 b | - |
| C16:0, % by GC, same as below | 9.68 ± 0.35 a | 2.62 ± 0.25 b | 7–10 |
| C18:0 | 5.32 ± 0.23 a | 3.21 ± 0.21 b | 2–4 |
| C18:1 | 29.36 ± 0.7 a | 20.62 ± 0.8 b | 17–33 |
| C18:2 | 39.95 ± 0.3 a | 50.68 ± 0.2 b | 40–47 |
| C18:3 9c 12c 15c | 1.65 ± 0.10 a | 2.58 ± 0.31 b | 0.4–1 |
| C20:2 11c 14c | 1.98 ± 0.14 a | 2.35 ± 0.16 a | 2–4 |
| C20:3 5c 1c 14c | 11.23 ± 0.43 a | 25.23 ± 0.45 b | 9–18 |
| SFA ** | 15.00 ± 0.51 a | 5.83 ± 0.48 b | 10–12 |
| MUFA ** | 29.36 ± 1.0 a | 23.62 ± 1.2 b | 19–35 |
| PUFA ** | 56.64 ± 1.5 a | 77.76 ± 1.4 b | 53–67 |
| UFA ** | 85.00 ± 1.9 a | 94.17 ± 1.3 b | 87–89 |
| Total tocopherols, mg/Kg | 1830 ± 25 a | 2020 ± 32 b | 1400–2300 |
| Total polyphenols, mg GAE**/kg | 5.6 ± 0.4 a | 2.3 ±0.3 b | 3.7–31.1 |
| Squalene, mg/kg | 15.6 ± 0.05 a | 16.2 ± 0.06 a | 16–35 |
| Total phytosterols, mg/kg | 2020 ± 80 a | 1980 ± 75 a | 1200–2200 |
* Values in the same row with different superscript letters are significant difference at p < 0.05. ** SFA:saturated fatty acid; MUFA: monounsaturated fatty acid; PUFA:polyunsaturated fatty acid; UFA:unsaturated fatty acid; GAE:gallic acid equivalent.
The properties of kernel oil after different dewaxing process (WP) and fractionation process (FP).
| Dewaxing/Fractionation Condition | Yield of Liquid Fraction % | Sciadonic Acid % | Melting Range | Solid Fat Content | Wax% |
|---|---|---|---|---|---|
| UT oil, original | - | 11.2 ± 0.8 a | 13.5 d–16.8 d | 10.9 ± 1.3 c | 2.12 ± 0.25 e |
| 96.8 ± 1.6 d | 11.5 ± 1.3 a | 12.3 d–15.6 d | 10.5 ± 1.6 c | 0.45 ± 0.09 d | |
| 76.6 ± 1.3 a | 19.7 ± 0.8 d | 4.3 b–7.8 b | 2.1 ± 0.8 a | 0.06 ± 0.00 a | |
| 80.7 ± 1.8 b | 15.3 ± 0.9 c | 4.6 b–8.3 b | 2.6 ± 0.6 b | 0.12 ± 0.02 b | |
| 75.2 ± 1.7 a | 25.2 ± 0.9 d | 3.2 a–5.6 a | 1.9 ± 0.8 a | 0.05 ± 0.00 a | |
| 88.6 ± 2.3 c | 13.9 ± 1.5 b | 5.5 c–9.2 c | 2.5 ± 0.3 b | 0.18 ± 0.02 c |
* Values in the same column with different superscript letters are significant difference at p < 0.05.
Figure 2AV (a), PV and AnV (b) of UT oil and FT oil in the long-term storage test.
Figure 3(a), PV and AnV (b) of UT oil and FT oil in a Schaal accelerated test. * The same lowercase letters means the no significant difference between values of different days in the same curve (p < 0.05). ** No significant difference between the curves of AV, PV and AnV for FT oil and UT oil (p < 0.05). *** Data are presented as mean ± SD, p < 0.05.
Scavenging ability and LOX-5 inhibition efficiency of different Torreya kernel oils.
| UT Oil | FT Oil | EGCG** | BHT | NDGA** | ||
|---|---|---|---|---|---|---|
| ORAC | 445 ± 12 a | 458 ± 10 a | 8000 ± 124 | 260–435 | - | - |
| DPPH | 485 ± 15 a | 502 ± 18 a | - | 422–509 | - | - |
| DPPH IC50 | 6.12 ± 0.05 a | 5.90 ± 0.12 a | 90 | - | 1.75 ± 0.03 | - |
| LOX-5 IE% | 32.1 ± 2.3 a | 65.2 ± 3.1 b | - | - | - | 100 ± 0 |
| LOX-5 IC50 | - | 47.8 ± 1.3 | - | - | - | 2.95 ± 0.21 |
* Values in the same row with different superscript letters are significant difference at p < 0.05. ** EGCG: epigallocatechin gallate; BHT:2,6-di-tert-butyl-4-methyl phenol; NDGA: nordihydro-guaiaretic acid.
Figure 4The inhibition efficiency of PDE-5 by UT oil and FT oil (a) and the comparison test with EDTA and L-cysteine (b), (data are presented as mean ± SD, p < 0.05).
Figure 5Effect of FT oil and UT oil on xylene induced ear inflammation in mice. (n = 15, Data are presented as mean ± SD, p < 0.05;1,2,3,4,5 right ear, 1′,2′,3′,4′,5′ left ear;.1,1′ control, 2,2′ with FT oil, 3,3′ with UT oil, 4,4′ with reference (UT oil with 2000 mg/kg tocopherols), 5,5′ with aspirin).